Roche Pays $580M For Biotech Developing Arthritis Treatment
By Fola Akinnibi ( October 9, 2015, 9:19 PM EDT) -- Swiss biotech giant Roche Holding will buy a venture capital-backed company based in California that is developing a treatment for rheumatoid arthritis and other autoimmune and inflammatory diseases in a deal worth up to $580 million....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.